If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEagle Eye Regulatory News (EYE)

Share Price Information for Eagle Eye (EYE)

Share Price is delayed by 15 minutes
Get Live Data
475.00    0.00 (0.00%)
Bid:
470.00
Ask:
480.00
Spread: 10.00 (2.128%)
Market Cap: £143.57m
EYE Live PriceLast checked at - London Stock Exchange

Intraday Eagle Eye Share Chart

Director share options amendment

16 Dec 2025 07:00

RNS Number : 6359L
Eagle Eye Solutions Group PLC
16 December 2025
 

16 December 2025

Eagle Eye Solutions Group PLC

("Eagle Eye" or the "Company")

 

Director share options amendment

Eagle Eye, a leading SaaS and AI technology company that creates digital connections enabling personalised, real-time marketing at scale, announces an amendment to its existing share option agreements with CEO Tim Mason and CFO Lucy Sharman-Munday in respect of the vested share options detailed below (the "Share Options"), dated January 2016 and September 2016 (the "Share Option Agreements"). The period in which they may exercise such Share Options is due to expire in January 2026 and September 2026 respectively. The Company considers it desirable to extend the expiry dates by 3 years and as of today, the Share Option Agreements have been amended accordingly pursuant to the terms of the Eagle Eye Solutions Group plc Long Term Incentive Plan scheme as set out below. All other terms of the Share Option Agreements remain unchanged.

Number of options amended

Current expiry date

Amended expiry date

Total options held

Total options held (%)

Tim Mason

334,470

04/01/26

04/01/29

Tim Mason

153,606

21/09/26

21/09/29

 

488,076

 

 

2,011,246

6.7%

Lucy Sharman-Munday

13,815

12/01/26

12/01/29

Lucy Sharman-Munday

58,520

21/09/26

21/09/29

 

72,335

 

 

736,504

2.4%

 

 

Enquiries:

Eagle Eye Solutions Group plc

Tel: 0844 824 3686

Robert Senior, Remuneration Committee Chair, NED

 

 

 

 

Investec Bank plc (Nominated Adviser and Joint Broker)

Tel: +44 20 7597 5970

David Anderson / Nick Prowting / James Smith

 

 

 

Shore Capital (Joint Broker)

Tel: +44 20 7408 4090

Corporate Advisory: Daniel Bush, David Coaten, Lucy Bowden

 

Corporate Broking: Henry Willcocks

 

 

 

Alma Strategic Communications

Tel: +44 20 3405 0205

Caroline Forde, Hannah Campbell, Kinvara Verdon

 

 

 

About Eagle Eye

 

Eagle Eye is a leading SaaS and AI company, enabling retail, travel and hospitality brands to earn lasting customer loyalty through harnessing the power of real-time, omnichannel and personalized marketing. Our powerful technology combines the world's most flexible and scalable loyalty and promotions capability with cutting edge, built-for-purpose AI to deliver 1:1 personalization at scale for enterprise businesses, globally.

 

Our growing customer base includes Loblaws, Southeastern Grocers, Giant Eagle, Asda, Tesco, Morrisons, JD Sports, E.Leclerc, Carrefour, the Woolworths Group and many more. Each week, more than 1 billion personalized offers are seamlessly executed via our platform, and over 700 million loyalty member wallets are managed worldwide. 

 

AI-powered, API-based and cloud-native, Eagle Eye's enterprise-grade technology is fully certified by the MACH Alliance and has received recognition from leading industry bodies, including Gartner, Forrester, IDC and QKS. 

 

Web - www.eagleeye.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUVUVRVBUUAAA
Date   Source Headline
19th Mar 20247:00 amRNSHalf Year Results
28th Feb 202410:19 amRNSAIM Rule 17: Additional Directorship Disclosures
22nd Feb 20247:00 amRNSCapital Markets Event
24th Jan 20241:23 pmRNSNotification of Major Holdings
22nd Jan 20243:55 pmRNSNotification of Major Holdings
22nd Jan 20241:33 pmRNSNotification of Major Holdings
22nd Jan 202410:12 amRNSPDMR Shareholding
19th Jan 202411:09 amRNSIssue of equity and PDMR shareholding
16th Jan 20247:00 amRNSH1 Trading Update and Notice of Results
11th Jan 20247:00 amRNSLaunch of EagleAI
8th Jan 20247:00 amRNSContract with PFG including first win for EagleAI
20th Dec 20237:00 amRNSContract secured with North American pet retailer
14th Dec 20233:45 pmRNSNotification of Major Holdings
21st Nov 20237:00 amRNSIssue of Share Options
16th Nov 20235:51 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Trading Statement
14th Nov 20237:00 amRNSFurther accolades for culture and innovation
3rd Nov 20235:33 pmRNSIssue of Equity & Director Shareholding
23rd Oct 20232:24 pmRNSIssue of Equity
19th Oct 20234:51 pmRNS2023 Annual Report and Accounts and Notice of AGM
26th Sep 20233:24 pmRNSReplacement - Final Results
25th Sep 20231:47 pmRNSIssue of Equity
19th Sep 20237:00 amRNSFinal Results
15th Sep 20237:00 amRNSChair Succession
22nd Aug 20237:00 amRNSEagle Eye selected by large Canadian retailer
11th Jul 20237:00 amRNSTrading Update
3rd Jul 20237:00 amRNSFive-year contract win with Morrisons
24th May 20237:00 amRNSSelected to join Grow London Global Programme
18th May 20237:00 amRNSUntie Nots first contract win in Singapore
15th May 20237:00 amRNSAppointment of Independent Non-Executive Director
11th May 20235:52 pmRNSIssue of Equity
25th Apr 20237:00 amRNSNew contract with The John Lewis Partnership
13th Apr 20233:58 pmRNSPDMR Shareholding
13th Apr 20237:00 amRNSIssue of equity and PDMR shareholding
5th Apr 20237:00 amRNSIssue of share options
5th Apr 20237:00 amRNSGrowth Share Plan
29th Mar 20233:16 pmRNSDirector/PDMR Shareholding
16th Mar 202310:25 amRNSNotification of Major Holdings
15th Mar 20239:38 amRNSIssue of Equity
14th Mar 20235:52 pmRNSHolding(s) in Company
14th Mar 20237:00 amRNSHalf Year Results
13th Mar 20237:00 amRNSUpdate regarding Silicon Valley Bank
23rd Feb 20237:00 amRNSDirectorate Change
10th Feb 20235:57 pmRNSIssue of equity and Director shareholding
20th Jan 20234:32 pmRNSIssue of Equity and Director Shareholding
18th Jan 20237:00 amRNSH1 Trading Update and Notice of Results
11th Jan 20235:40 pmRNSHolding(s) in Company
3rd Jan 20233:01 pmRNSCompletion of acquisition and Issue of equity
28th Nov 20221:43 pmRNSIssue of Equity
22nd Nov 20226:13 pmRNSIssue of equity and Director shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.